PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation-Reference-Cited by-同舟云学术

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation

Published:2005-08-04 Issue:12 Volume:128 Page:2777-2785
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Adams John R.,van Netten Hinke,Schulzer Michael,Mak Edwin,Mckenzie Jessamyn,Strongosky Audrey,Sossi Vesna,Ruth Thomas J.,Lee Chong S.,Farrer Matthew,Gasser Thomas,Uitti Ryan J.,Calne Donald B.,Wszolek Zbigniew K.,Stoessl A. Jon

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/128/12/2777/1164907/awh607.pdf

Reference48 articles.

1. Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, et al. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol2005; 57: 762–5.

2. Adam MJ, Ruth TJ. Synthesis and purification of L-6-[18F]fluorodopa. Appl Radiat Isot1988; 39: 1203–6.

3. Arawaka S, Saito Y, Murayama S, Mori H. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology1998; 51: 887–9.

4. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol1990; 28: 547–55.

5. Broussolle E, Lucking CB, Ginovart N, Pollak P, Remy P, Durr A. [18F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations. Neurology2000; 55: 877–9.

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging perspectives on precision therapy for Parkinson’s disease: multidimensional evidence leading to a new breakthrough in personalized medicine;Frontiers in Aging Neuroscience;2024-07-04

2. Concerns with the new biological research criteria for synucleinopathy – Authors' reply;The Lancet Neurology;2024-07

3. Regional nigral neuromelanin degeneration in asymptomatic leucine-rich repeat kinase 2 gene carrier using MRI;Scientific Reports;2024-05-09

4. Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease;Journal of Parkinson's Disease;2024-02-03

5. Multi-tracer PET correlation analysis reveals disease-specific patterns in Parkinson’s disease and asymptomatic LRRK2 pathogenic variant carriers compared to healthy controls;NeuroImage: Clinical;2024